Table 3.
Distribution of XDR, MDR and Non-MDR samples among P.aeruginosa clinical isolates obtained from different clinical sources and different hospitals
| Hospital | Clinical source | Number of isolates | XDR no N = 53 |
MDR no N = 13 |
Non-MDR no N = 4 |
χ2/MC | P value |
|---|---|---|---|---|---|---|---|
| H1 | burn | 13 | 10 | 3 | 0 | 1.09 | 0.579 |
| wound | 14 | 13 | 1 | 0 | 2.91 | 0.233 | |
| urine | 16 | 15 | 0 | 1 | 4.75 | 0.093 | |
| sputum | 6 | 3 | 3 | 0 | 4.44 | 0.109 | |
| blood | 2 | 2 | 0 | 0 | 0.66 | 0.719 | |
| pus | 1 | 0 | 1 | 0 | 4.45 | 0.108 | |
| H2 | Burn | 11 | 6 | 5 | 0 | 6.59 | 0.036* |
| Wound | 3 | 2 | 0 | 1 | 4.8 | 0.09 | |
| pus | 1 | 1 | 0 | 0 | 0.325 | 0.850 | |
| H3 | burn | 3 | 1 | 0 | 2 | 21.70 | 0.0001* |
| Total no. of isolates | 70 | 53 | 13 | 4 | |||
XDR Extensively-drug resistant, MDR Multidrug-resistant, Non-MDR Non- multidrug resistant, MC Monte Carlo test, χ2 Chi-Square test, P probability
(*) means significant